Validation of gallium-68 PSMA-PET/CT for primary lymph node staging in prostate cancer patients

被引：0
|
作者：
van Kalmthout, L. [1 ]
van Melick, H. [2 ]
Lavalaye, J. [2 ]
Meijer, R. [1 ]
Kooistra, A. [3 ]
de Klerk, J. [3 ]
Braat, A. [4 ]
Kaldeway, P. [5 ]
de Keizer, B. [1 ]
Lam, M. [1 ]
机构：
[1] Acad Hosp, Utrecht, Netherlands
[2] St Antonius Hosp, Nieuwegein, Netherlands
[3] Meander Med Ctr, Amersfoort, Netherlands
[4] UMC Utrecht, Utrecht, Netherlands
[5] St Anotnius Hosp, Nieuwegein, Netherlands
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2019年 / 46卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-776
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [21] Primary staging of prostate cancer using 68Ga-PSMA PET/CT
    Graziani, T.
    Scarlattei, M.
    Baldari, G.
    Migliari, S.
    Sammartano, A.
    Gasparro, D.
    Maestroni, U.
    Ruffini, L.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S599 - S600
  • [22] Accuracy of 68Ga-PSMA PET-CT and PET-MRI in lymph node staging for localized prostate cancer
    Gomes Barbosa, Alan Roger
    Amaral, Breno Santos
    Lourenco, Danilo Budib
    Bianco, Bianca
    Gushiken, Felipe Arakaki
    Apezzato, Marcelo
    Silva, Julia Francisco
    da Cunha, Marcelo Livorsi
    Filippi, Renee Zon
    Baroni, Ronaldo Hueb
    Lemos, Gustavo Caserta
    Carneiro, Arie
    EINSTEIN-SAO PAULO, 2022, 20 : eAO6599
  • [23] PSMA-PET/CT AND WHOLE-BODY MRI FOR STAGING AND RESTAGING OF PROSTATE CANCER PATIENTS
    Greco, Elena
    Bianchi, Lorenzo
    Gaudiano, Cristina
    Corcioni, Beniamino
    Spinozzi, Luca
    Catanzaro, Calogero
    Mignogna, Chiara
    Renzetti, Benedetta
    Cattabriga, Arrigo
    Schiavina, Riccardo
    Brunocilla, Eugenio
    Mosconi, Cristina
    Castellucci, Paolo
    Fanti, Stefano
    Farolfi, Andrea
    ANTICANCER RESEARCH, 2024, 44 (10)
  • [24] Hybrid 68Ga-PSMA PET-CT for primary prostate cancer staging
    Lee, J.
    BJU INTERNATIONAL, 2017, 119 : 55 - 56
  • [25] PSMA-PET-CT for primary staging in patients with advanced prostate cancer
    Cappel, Cedric Curt
    Dopcke, Denise
    Dunst, Juergen
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (03) : 257 - 260
  • [26] Histopathological characteristics of prostate cancer lymph node metastasis with false-negative PSMA-PET/CT findings
    Kroon, L.
    Kweldam, C.
    van Leenders, G.
    VIRCHOWS ARCHIV, 2024, 485 : S532 - S533
  • [27] Outcomes & predictors of progression: SBRT for lymph node oligorecurrent prostate cancer on PSMA-PET
    Werensteijn-Honingh, A.
    Wevers, A.
    Peters, M.
    Kroon, P.
    Intven, M.
    Eppinga, W.
    Jurgenliemk-Schulz, I.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S573 - S575
  • [28] Number of PSMA-PET positive lymph nodes affects outcome in node positive prostate cancer patients
    Spohn, S.
    Birkenmaier, V.
    Ruf, J.
    Sprave, T.
    Grosu, A.
    Zamboglou, C.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1196 - S1197
  • [29] The role of salvage lymph node dissection and PSMA-PET in recurrent prostate cancer Comment
    Kalampokis, Nikolaos
    Grivas, Nikolaos
    GLAND SURGERY, 2020, 9 (04) : 1080 - 1081
  • [30] RETROSPECTIVE EVALUATION OF GALLIUM-68 PSMA PET ACCURACY, ADDITIONAL FINDINGS AND CHANGE MANAGEMENT IN PATIENTS WITH PROSTATE CANCER
    Calnan, D.
    Bartholomeusz, D.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 28 - 29
12345